Cite Filings / OTLK / 0001558370-22-019036
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-K

Annual Report

Outlook Therapeutics, Inc. · Filed 2022-12-29 · Acc 0001558370-22-019036

Documents 1

  • 10-K Annual Report , otlk-20220930x10k.htm

Around this filing

  • 2023-12-22 10-K Annual Report
  • 2022-12-29 10-K Annual Report
  • 2022-12-29 8-K Results of operations
  • 2022-12-29 4 Director acquired 14,230,418 shares (grant or award)
  • 2022-12-29 SC 13D/A Beneficial Ownership Report
  • 2022-12-23 8-K Material agreement · Unregistered share sale · Other events
  • 2021-12-23 10-K Annual Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading otlk-20220930x10k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…